
CBL-514
Selective Adipocyte Apoptosis · Lipolytic Sculptor
CBL-514 is a designer small-molecule injectable that induces selective apoptosis (programmed cell death) exclusively in fat cells at the injection site — permanently eliminating them without damaging surrounding skin, muscle or nerves. Unlike traditional fat-burners that merely shrink adipocytes, CBL-514 kills them. Once they're gone, they're gone for good.
- Surgical-grade localized fat reduction without a scalpel — eliminates stubborn fat deposits that resist strict diets and heavy training
- Precision targeting — the compound king for sculpting double chin (submental), love handles (flanks), lower abdomen, axillary area and saddlebags
- Cellulite reduction (firming effect) — destroys accumulated fat chambers that push skin outward, smoothing the surface and visibly reducing orange-peel texture
- Non-surgical lipoma treatment — actively researched as the first effective non-surgical protocol for dissolving painful or unsightly benign fat tumors
- Zero downtime — unlike liposuction or aggressive cryolipolysis, resume normal activity immediately after the protocol
Technical sheet.
- Compound
- CBL-514
- Form
- Injectable solution
- Purity
- ≥ 99.0%
Room temperature, sealed, dry. Protect from light.
Where teams use it.
- 01Non-surgical localized fat elimination
- 02Cellulite reduction and skin-surface smoothing
- 03Submental (double-chin) sculpting
- 04Body-contouring protocols for diet-resistant areas
Related products.

Retatrutide
Triple Agonist · GLP-1 + GIP + Glucagon
The first triple-agonist ever developed — activates GLP-1, GIP and Glucagon receptors simultaneously for up to 24% body-weight loss, shattering every medical record.

Tirzepatide
Dual Agonist · GLP-1 + GIP
A fatty-acid-modified dual incretin agonist that crushes semaglutide — delivering up to 20.9% weight loss with fewer side effects and complete food-noise silence.